Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients

Jinling Ma, Suyan Bian, Meng Gao Department of Geriatric Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of ChinaCorrespondence: Jinling Ma, Department of Geriatric Cardiology, the Se...

Full description

Bibliographic Details
Main Authors: Ma J, Bian S, Gao M
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/prediction-of-outcomes-through-cystatin-c-and-ctni-in-elderly-type-2-m-peer-reviewed-fulltext-article-CIA
_version_ 1797736288918437888
author Ma J
Bian S
Gao M
author_facet Ma J
Bian S
Gao M
author_sort Ma J
collection DOAJ
description Jinling Ma, Suyan Bian, Meng Gao Department of Geriatric Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of ChinaCorrespondence: Jinling Ma, Department of Geriatric Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People’s Republic of China, Email majinling1@163.comBackground: Chronic kidney disease (CKD) and coronary artery disease (CAD) are strongly associated. Cystatin C (Cys C) is a more sensitive marker of early renal insufficiency. This study aimed to evaluate the prognostic implications of combined of Cys C and cardiac troponin I (cTnI) on 90-day outcomes in elderly patients with type 2 myocardial infarction (MI).Methods: The data of consecutive type 2 MI patients aged 80 years and older who received Cys C and cTnI measurements within 24 h of admission were retrospectively reviewed. The endpoint was a 90-day all-cause and cardiac mortality.Results: A total of 4326 patients were included. During the 90-day follow-up period, a higher all-cause and cardiac mortality was observed in patients with Cys C ≥ 1.49mg/L than in patients with Cys C < 1.49 mg/L (P < 0.001). After the multivariate logistic regression adjustments, the higher CysC and cTnI levels remained independent predictors of the 90-day all-cause mortality and cardiac mortality. Moreover, the Kaplan–Meier all-cause and cardiac mortality event-free survival curves showed that the patients with the presence of elevated levels of both Cys C and cTnI had a significantly increased risk than those with Cys C or cTnI alone.Conclusion: Elevated Cys C level is an independent risk factor for all-cause and cardiac mortality in the elderly type 2 MI population. The predictive ability of the combined use of Cys C and cTnI in elderly type 2 MI patients is stronger than that of Cys C or cTnI alone.Keywords: myocardial infarction, cystatin C, elderly
first_indexed 2024-03-12T13:11:30Z
format Article
id doaj.art-a09e3dd21a6247388286ed25432a32d1
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-03-12T13:11:30Z
publishDate 2023-08-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-a09e3dd21a6247388286ed25432a32d12023-08-27T18:55:12ZengDove Medical PressClinical Interventions in Aging1178-19982023-08-01Volume 181415142286188Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction PatientsMa JBian SGao MJinling Ma, Suyan Bian, Meng Gao Department of Geriatric Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of ChinaCorrespondence: Jinling Ma, Department of Geriatric Cardiology, the Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, No. 28, Fuxing Road, Haidian District, Beijing, 100853, People’s Republic of China, Email majinling1@163.comBackground: Chronic kidney disease (CKD) and coronary artery disease (CAD) are strongly associated. Cystatin C (Cys C) is a more sensitive marker of early renal insufficiency. This study aimed to evaluate the prognostic implications of combined of Cys C and cardiac troponin I (cTnI) on 90-day outcomes in elderly patients with type 2 myocardial infarction (MI).Methods: The data of consecutive type 2 MI patients aged 80 years and older who received Cys C and cTnI measurements within 24 h of admission were retrospectively reviewed. The endpoint was a 90-day all-cause and cardiac mortality.Results: A total of 4326 patients were included. During the 90-day follow-up period, a higher all-cause and cardiac mortality was observed in patients with Cys C ≥ 1.49mg/L than in patients with Cys C < 1.49 mg/L (P < 0.001). After the multivariate logistic regression adjustments, the higher CysC and cTnI levels remained independent predictors of the 90-day all-cause mortality and cardiac mortality. Moreover, the Kaplan–Meier all-cause and cardiac mortality event-free survival curves showed that the patients with the presence of elevated levels of both Cys C and cTnI had a significantly increased risk than those with Cys C or cTnI alone.Conclusion: Elevated Cys C level is an independent risk factor for all-cause and cardiac mortality in the elderly type 2 MI population. The predictive ability of the combined use of Cys C and cTnI in elderly type 2 MI patients is stronger than that of Cys C or cTnI alone.Keywords: myocardial infarction, cystatin C, elderlyhttps://www.dovepress.com/prediction-of-outcomes-through-cystatin-c-and-ctni-in-elderly-type-2-m-peer-reviewed-fulltext-article-CIAmyocardial infarctioncstatin celderly
spellingShingle Ma J
Bian S
Gao M
Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
Clinical Interventions in Aging
myocardial infarction
cstatin c
elderly
title Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
title_full Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
title_fullStr Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
title_full_unstemmed Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
title_short Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
title_sort prediction of outcomes through cystatin c and ctni in elderly type 2 myocardial infarction patients
topic myocardial infarction
cstatin c
elderly
url https://www.dovepress.com/prediction-of-outcomes-through-cystatin-c-and-ctni-in-elderly-type-2-m-peer-reviewed-fulltext-article-CIA
work_keys_str_mv AT maj predictionofoutcomesthroughcystatincandctniinelderlytype2myocardialinfarctionpatients
AT bians predictionofoutcomesthroughcystatincandctniinelderlytype2myocardialinfarctionpatients
AT gaom predictionofoutcomesthroughcystatincandctniinelderlytype2myocardialinfarctionpatients